Halm, Dan R., and Susan Troutman Halm. Prostanoids stimulate K secretion and Cl secretion in guinea pig distal colon via distinct pathways. Am J Physiol Gastrointest Liver Physiol 281: G984-G996, 2001.-Short-circuit current (Isc) and transepithelial conductance (Gt) were measured in guinea pig distal colonic mucosa isolated from submucosa and underlying muscle layers. Indomethacin (2 M) and NS-398 (2 M) were added to suppress endogenous production of prostanoids. Serosal addition of PGE 2 (10 nM) stimulated negative Isc consistent with K secretion, and concentrations Ͼ30 nM stimulated positive Isc consistent with Cl secretion. PGE2 also stimulated Gt at low and high concentrations. Dose responses to prostanoids specific for EP prostanoid receptors were consistent with stimulating K secretion through EP2 receptors, based on a rank order potency (from EC50 values) of PGE2 (1.9 nM) Ͼ 11-deoxy-PGE1 (8.3 nM) Ͼ 19(R)-hydroxy-PGE2 (13.9 nM) Ͼ butaprost (67 nM) Ͼ 17-phenyl-trinor-PGE 2 (307 nM) Ͼ Ͼ sulprostone (Ͼ10 M). An isoprostane, 8-iso-PGE2, stimulated K secretion with an EC50 of 33 nM. Cl secretory response was stimulated by PGD 2 and BW-245C, a DP prostanoid receptor-specific agonist: BW-245C (15 nM) Ͼ PGD 2 (30 nM) Ͼ PGE2 (203 nM). Agonists specific for FP, IP, and TP prostanoid receptors were ineffective in stimulating Isc and Gt at concentrations Ͻ1 M. These results indicate that PGE 2 stimulated electrogenic K secretion through activation of EP 2 receptors and electrogenic KCl secretion through activation of DP receptors. Thus stimulation of Cl secretion in vivo would occur either via physiological concentrations of PGD 2 (Ͻ100 nM) or pathophysiological concentrations of PGE 2 (Ͼ100 nM) that could occur during inflammatory conditions. prostaglandin E2; prostaglandin D2; isoprostane; inflammation
prostaglandin E2; prostaglandin D2; isoprostane; inflammation FLUID SECRETION IN THE INTESTINES promotes digestion by dispersing the contents for access to absorptive sites and for propulsion toward more distal locations. Excessive fluid secretion increases luminal transit, which limits absorption and leads to loss of body fluid. Active ion secretion drives this production of fluid, such that regulatory pathways acting on ion transporters in secretory cells control the rate of fluid secretion (19, 20) . Prostanoids are powerful stimulators of ion secretion, producing high, sustained rates across colonic epithelial cells. Electrogenic secretion of both Cl and K is stimulated in guinea pig and rabbit distal colon by PGE 2 at high concentrations (Ͼ100 nM). Colonic epithelial cells produce this KCl secretion by an electrogenic mechanism similar to that found in other fluid secretory epithelia (19, 20, 24, 25) . Active K secretion can be stimulated in the absence of active Cl secretion by epinephrine (20, 43) , aldosterone (21) , and low concentrations of PGE 2 (Ͻ30 nM) (43) . Thus not only the rate but also the ionic composition of secreted fluid can be controlled by variations in secretory stimuli.
Intestinal inflammation brought on by infection or idiopathic conditions such as ulcerative colitis occurs with elevated levels of PGE 2 (26, 32) . Consequent stimulation of Cl secretion leads to fluid secretion and symptoms of diarrhea. PGE 2 , however, is just one of a large number of compounds released for signaling by cells in the mucosa. This intercellular communication is necessary to coordinate various functions including fluid transport, mucus secretion, muscle contraction, blood flow, as well as immune recognition and defense (8) . Fluid secretion driven by ion flows serves a general function of limiting residence of infectious agents in the intestinal lumen, but extreme rates may result from inappropriate levels of stimulators that occur during acute responses. The extent of secretory stimulation that results from pathophysiological signaling has not been determined fully.
Elucidation of secretory regulation in colonic epithelia has been confounded by the presence of neural elements and immune system components within the mucosa that can release signaling molecules in response to diverse stimuli (8) . Neural involvement has been demonstrated by direct nerve stimulation, inhibition of nerve conduction with tetrodotoxin, or synaptic interference with blockers such as atropine and -conotoxins (2, 4, 13, 16, 17, 28, 48, 49) . Several extracellular signaling molecules have been shown to act through stimulating production of prostanoids, generally PGE 2 (4, 7, 44, 53) . Routinely this connection is implicated by using compounds such as indomethacin to inhibit cyclooxygenase (COX) that leads to synthesis of prostanoids. Other studies have limited the involvement of extraepithelial elements by dissection that maintains an intact epithelium so that transepithelial flow can be measured while several ancillary cell types are removed (2, 7, 13, 18, 30, 44) . In particular, removal of muscle layers and submucosa largely eliminates influences of enteric nerves on ion transport (13, 18, 30) .
Arachidonic acid can be converted to prostanoids through the action of COX and specific synthases (10, 38) , producing PGD 2 , PGE 2 , PGF 2␣ , PGI 2 (prostacyclin), and TxA 2 (thromboxane). Receptors selectively responsive to each of these prostanoids have been identified: DP, EP, FP, IP, and TP, respectively (38) . Prostanoid EP receptors constitute a group of four distinct genes (EP 1 , EP 2 , EP 3 , and EP 4 ), giving a total of eight presently known prostanoid receptors. Although prostanoid receptors generally interact with one of the five major prostanoid types with EC 50 values of 1-10 nM (1, 5, 31) , most of these receptors also have significant affinity for other prostanoids. Cross-sensitivity of these receptors at high agonist concentrations (Ͼ100 nM) is one reason that prostanoid responses often have been difficult to characterize.
The study reported here used isolated mucosa from guinea pig distal colon to establish secretory influences of prostanoids at the epithelium. Previous measurements of unidirectional isotopic fluxes (43) demonstrated that Cl and K secretion account quantitatively for stimulation of short-circuit current (I sc ) by PGE 2 . Pharmacologically defined prostanoid derivatives provided a means to distinguish activation via various prostanoid receptor subtypes. The results demonstrated that PGE 2 stimulated K secretion at concentrations Ͻ100 nM by activating the prostanoid receptor EP 2 subtype. In addition, PGE 2 stimulated electrogenic KCl secretion at concentrations Ͼ100 nM, likely through activation of the prostanoid receptor DP subtype, such that PGD 2 would be a physiological stimulator of colonic Cl secretion.
METHODS
Male guinea pigs (400-600 g body wt) received standard guinea pig chow and water ad libitum. Guinea pigs were killed by decapitation in accordance with a protocol approved by the Wright State University Institutional Laboratory Animal Care and Use Committee. Distal colon was removed and defined as the ϳ20-cm-long segment ending roughly 5 cm from the rectum. Colonic segments were cut open along the mesenteric line and flushed with ice-cold Ringer solution to remove fecal pellets. Epithelium was separated from underlying submucosa and muscle layers using a glass slide to gently scrape along the length of the colonic segment. The plane of dissection occurred at the base of crypts such that only components of the mucosa immediately adherent to the epithelium remained. Four mucosal sheets from each animal were mounted in Ussing chambers with an aperture of 0.64 cm 2 . These sheets were supported on the serosal face by Nuclepore filters (Whatman), with a thickness of ϳ10 m and a pore diameter of 5 m. Bathing solutions (10 ml) were circulated by gas lift through water-jacketed reservoirs that were maintained at 38°C. Standard Ringer solution contained (in mM) 145 Na Dose responses of Isc and Gt to prostanoids were fit to Henri-Michaelis-Menten binding curves using a nonlinear least-squares procedure. Prior findings with guinea pig distal colon indicate that PGE2 stimulates both negative and positive Isc components with EC50 values separated by ϳ300-fold (43) . Those dose responses with more than one inflection were fit to the sum of two independent binding curves
with total Isc or Gt as a combination of these two components (IA and IB; GA and GB) at each concentration (C). A similar analysis has allowed interpretation of pharmacological responses to agonists producing two distinct actions (47) . Secretory responses to agonists also were compared using equivalent electromotive force (EMF) (27, 55) 
RESULTS
Guinea pig distal colonic epithelium spontaneously secretes Cl and K when mounted in Ussing chambers (43) . This secretory activity can be reduced by suppressing prostanoid production with COX inhibitors such as indomethacin or can be stimulated by adding PGE 2 to the bathing solution. Initial I sc after mounting in Ussing chambers, in the presence of indomethacin (2 M), decreased from near zero toward a negative value approaching Ϫ4 eq ⅐ cm Ϫ2 ⅐ h Ϫ1 before returning to a less negative value (Fig. 1A) . G t decreased by approximately twofold over this same time interval (Fig. 1B) , consistent with reduction of electrogenic ion transport. Any substances released from isolated mucosa were washed from the chambers by replacing bathing solution in the reservoirs. Three washes generally produced maximal change in I sc and G t (Fig. 1) . Prostanoid production was suppressed further with a COX-2 inhibitor (12), NS-398 (2 M). Equivalent EMF of the I sc component suppressed by washing and COX inhibition (Fig. 1C) was similar to the EMF for electrogenic K secretion stimulated by aldosterone (21) or epinephrine (43) . Addition of amiloride (100 M) to the mucosal solution inhibited electrogenic Na absorption ( Fig. 1 ) such that electrogenic transport was in a consistent basal state.
Addition of PGE 2 stimulated both K secretion and Cl secretion in a concentration-dependent manner (Fig. 2) as reported previously (43) . A low concentration of 10 nM produced a large negative I sc ( Fig. 2A) and an increase in G t (Fig. 2B) , consistent with stimulation of K secretion. Secretory EMF (Fig. 2C) was Ϫ22 mV, similar to the value measured previously for electrogenic K secretion (21, 43) . Subsequent increase of PGE 2 concentration to 3 M resulted in a positive change in I sc and further increase in G t , consistent with stimulation of Cl secretion. Although steady-state I sc was near zero, previous Cl flux measurements (43) indicate that this change in I sc and G t resulted from stimulated Cl secretion in addition to ongoing K secretion. Blockade of residual nerve activity with TTX (1 M) or atropine (10 M) did not alter the response to PGE 2 (data not shown), similar to observations with mucosal preparations of rat distal colon (13) and ca- , and EMF (C). Initial condition followed 3 washes (see Fig. 1 ) and included indomethacin (2 M), NS-398 (2 M), and amiloride (100 M). EMF of stimulated electrogenic transport was calculated in reference to Isc and Gt at time 0 (see METHODS). PGE2 was added to serosal solution: 10 nM at time 0, 3 M at ϳ15 min. Bumetanide (100 M) was added to serosal solution. Fig. 1 . Initial secretory state of isolated colonic mucosa. A representative time course is shown, starting at initial setup, of short-circuit current (Isc, A) and transepithelial conductance (Gt , B) from guinea pig distal colon epithelium. Indomethacin (2 M) was added to both bathing solutions at time 0. Tissues were washed by draining and replacing the mucosal and serosal bathing solutions in the reservoirs, producing a ϳ20:1 dilution of remaining substances in the tissue chamber. Washing 3 times resulted in ϳ8,000-fold dilution. NS-398 (2 M), a selective cyclooxygenase 2 inhibitor, was added to both solutions at ϳ90 min. Amiloride (100 M) was added to mucosal solution. Electromotive force (EMF; see METHODS) of the electrogenic transport (C) that declined during initial setup period was calculated from Isc and Gt compared with values at 100 min; ⌬Isc and ⌬Gt after the 3rd wash were too small to provide a reliable estimate of EMF.
nine proximal colon (30) . Blockade of transmitter release with the combined presence of 300 nM -conotoxin-GVIA and 300 nM -conotoxin-MVIIC (-CgTx), inhibitors of synaptic Ca 2ϩ channels (3, 28, 49) , also did not alter the response to PGE 2 (data not shown). Addition of bumetanide (100 M) to the serosal solution resulted in a positive I sc and a decrease in G t , as shown previously to occur from complete inhibition of K Tables 1 and 2 . Control and bumetanide-inhibited conditions are also shown. *Bumetanide-insensitive Isc significantly different from 0 (P Ͻ 0.05) (A and B). Error estimates for Gt (C and D) were calculated after subtracting control value for each tissue. E: current and conductance fit to each component are plotted (see Tables 1 and 2 ). Values from negative current (F) and positive current (OE) responses were fit by least squares, and slope of line is secretory EMF, Ϫ24.7 mV and ϩ13.0 mV, respectively.
secretion and only partial inhibition of Cl secretion (43) . The large positive EMF ( Fig. 2C ) was consistent with continuing Cl secretion in the absence of K secretion. Activation of sustained ion secretion. Concentrationrelated stimulation of K and Cl secretion suggested independent stimulatory pathways, possibly through actions of PGE 2 at multiple receptors. Because prostanoid receptors of the EP subtype have affinities for PGE 2 in the low nanomolar range (1, 5, 10, 31), sensitivity to stimulation by agonists with defined affinity for EP receptor subtypes (10, 38) was tested. Secretion was measured from steady-state I sc and G t 20 min after each concentration increase. This time interval was sufficient for I sc to relax after concentration steps smaller than those shown in Fig. 2 . These dose responses of steady-state I sc and G t (Fig. 3 ) exhibited complex curvature suggesting two interactions (47) with stimulatory pathways for K and Cl secretion. Independent fits of I sc and G t to binding curves (see METHODS) produced identical rank order potencies and similar EC 50 values for each agonist (Table 1 ). For the negative I sc response, the observed rank order potency of PGE 2 Ͼ 11-deoxy-PGE 1 (11dPGE 1 ) Ͼ 19(R)-hydroxy-PGE 2 (19hPGE 2 ) Ͼ butaprost Ͼ 17-phenyl-trinor-PGE 2 (17pPGE 2 ) Ͼ Ͼ sulprostone supports involvement of EP 2 receptors. The similarity of EMF stimulated by these agonists (Table 1 and Fig. 3E ) suggests that the identical transport process was stimulated in each case. Because the EMF for these responses was similar to the K secretory EMF (21, 43) , the EP 2 prostanoid receptor is likely an initiator of K secretion.
Stimulation of Cl secretory I sc had EC 50 values in the micromolar range ( Fig. 3 and Table 2 ), suggesting that these agonists also were interacting with another class of receptor. Agonists selective for other prostanoid receptors were tested for efficacy in stimulating Cl secretion: BW-245C for DP, fluprostenol for FP, carbaprostacyclin for IP, and I-BOP for TP (10, 38) . Only BW-245C stimulated I sc and G t significantly, either alone or during K secretion stimulated with 10 nM PGE 2 (Fig. 4) . Inhibition of nerve activity with TTX (10 M) or atropine (10 M) did not alter steady-state responses to BW-245C or PGD 2 (data not shown). Activation with BW-245C produced a steady-state stimulation similar to PGE 2 ( Fig. 4) but only partially reproduced the transient component of I sc . The similarity of EMF suggests that the identical transport process produced responses to BW-245C and high-concentration PGE 2 (Fig. 4C ). In addition, the DP agonist alone appeared to stimulate electrogenic KCl secretion similar to high-concentration PGE 2 (Ref. 43 ; Fig. 2C ), based on EMF (Fig. 4C) and a large increase in G t (Fig.  4B ). Inhibition with bumetanide (Fig. 4) produced similar results in paired tissues, indicating that DP receptors also activated bumetanide-insensitive secretory I sc . EMF with bumetanide ( Fig. 4C ) was consistent with Cl secretion remaining after complete inhibition of K secretion, as observed previously (43) .
Addition of either PGD 2 or BW-245C resulted in I sc becoming more negative at low concentrations and more positive at higher concentrations (Fig. 5A) , although not as pronounced nor over as wide a concentration range as with PGE 2 . Dose responses of G t to either PGD 2 or BW-245C could be fit readily with a single binding curve (Fig. 5B) . The small decline in I sc with either DP agonist may simply reflect slightly greater sensitivity for activation of K secretion than for Cl secretion, such that the actual EC 50 of the I sc response would be between these two values ( Table 3) . Values are means Ϯ SE; n ϭ no. of mucosal samples. Isc, short-circuit current; Gt, transepithelial conductance; 11dPGE1, 11-deoxy-PGE1; 19hPGE2, 19(R)-hydroxy-PGE2; 17pPGE2, 17-phenyl-trinor-PGE2; 8iPGE2, 8-iso-PGE2. Cumulative dose responses were fit with 2 additive binding curves (see Fig. 3 Values are means Ϯ SE; n ϭ no. of mucosal samples. Cumulative dose responses were fit with 2 additive binding curves (see For electrogenic KCl secretion, G t measurements have the advantage of not depending on the direction of transepithelial charge flow. Together these results suggest that PGD 2 and BW-245C both acted at only a single receptor type to produce electrogenic KCl secretion. EC 50 values obtained with G t responses (Tables 2  and 3 ) produced a rank order potency supporting involvement of DP receptors: BW-245C Ͼ PGD 2 Ͼ PGE 2 Ͼ butaprost Ͼ 11dPGE 1 ϭ 19hPGE 2 Ͼ 8-iso-PGE 2 (8iPGE 2 ) Ͼ Ͼ 17pPGE 2 and carbaprostacyclin Ͼ Ͼ fluprostenol, I-BOP, and sulprostone. The inability of fluprostenol, I-BOP, or sulprostone to stimulate I sc or G t also underscores that the observed actions of PGE 2 were not a generalized response to prostanoids.
In an attempt to determine action on Cl secretion independent of graded K secretory responses, K secretion was stimulated with 10 nM PGE 2 before dose responses with DP agonists (Fig. 5) . Both I sc and G t responses could be fit with single binding curves, but the resulting EC 50 values obtained from I sc responses were larger than from G t responses (Table 3) . These higher EC 50 values for I sc measurements may reflect a small portion of stimulated K secretion that still occurs with greater sensitivity than for Cl secretion, such that positive deflections in I sc occur at higher concentrations. Because the specific DP receptor antagonist BWA-868C (10) is no longer commercially available, a direct test of PGE 2 action at DP receptors was not possible.
Positive I sc was stimulated by PGE 2 , PGD 2 , or BW-245C, in the presence of bumetanide (Fig. 6) . Previous flux measurements support the idea that this PGE 2 -stimulated I sc is Cl secretion without any accompanying K secretion (43) . Although PGE 2 produced higher steady-state I sc and G t , PGD 2 and BW-245C activated with generally lower EC 50 values (Figs. 5 and 6 ; Table  3 ). This response to PGD 2 and BW-245C was identical when measured during stimulation with 10 nM PGE 2 (data not shown), indicating that the larger response by PGE 2 likely was not caused by an additional activation of EP receptors. Addition of 10 M PGE 2 after Fig. 5 . Secretory dose response to DP receptor agonists. Cumulative dose responses of PGE2, PGD2, and BW-245C were measured for steady-state Isc (A) and Gt (B). BW-245C is a DP receptor-selective agonist (PGD2 analog). Each dose response was fit to binding curves as in Fig. 3 . Responses of Gt to PGD2 and BW-245C required only a single binding curve for fitting. In 2 groups ({, ‚), PGE2 (10 nM) was added before dose response. Nos. of experiments averaged for each dose response are listed in Table 3 . Control and bumetanide-inhibited conditions are also shown. *Bumetanide-insensitive Isc significantly different (P Ͻ 0.05) from PGE2 condition (A). Error estimates for Gt (B) were calculated after subtracting control value for each tissue. stimulation with either PGD 2 or BW-245C (10 M) increased I sc and G t (Fig. 6) , consistent with a greater secretory rate through PGE 2 action.
Activation of transient ion secretion. Previous measurements of secretory activation by prostanoids in guinea pig distal colon focused on maximal I sc responses (16, 17, 50) . Maximal I sc response to PGE 2 generally was dominated by transient components, and BW-245C stimulated much smaller transient I sc (Figs. 2 and 4) . The positive secretory EMF during the first 5 min of stimulation (Fig. 4C) , together with previous flux measurements (43) , is consistent with Cl secretion as the source of the transient I sc . Comparison of I sc responses during concentration steps of dose responses (Fig. 5) shows that BW-245C and PGD 2 produced steep early rises in I sc that were small and dominated by the later steady-state plateau (Fig. 7A) . EP agonists 11dPGE 1 and 19hPGE 2 also produced steep early increases in I sc that were attenuated (Fig.  7B) . The time course of stimulation by the EP 2 agonist butaprost was much delayed (Fig. 7B) , which may have resulted from slow conversion to the more potent free acid form (1, 5) . The isoprostane 8iPGE 2 also did not produce a noticeable transient I sc response (data not shown). These results indicate that agonists for DP and EP prostanoid receptors are relatively weak stimulators of the transient I sc response.
Transient components were measured as the difference between maximal I sc and subsequent steady-state I sc ; because of large variability among responses at ϳ1 min ( Figs. 2A and 4A ), maximal I sc was measured ϳ2 min into the response. Also, in a few experiments, TTX (1 M) reduced peak I sc stimulated by BW-245C (3 M) at ϳ1 min by ϳ2 eq ⅐ cm Ϫ2 ⅐ h Ϫ1 without altering latter parts of the response (data not shown). Dose responses of transient I sc to PGE 2 (from experiments in Fig. 5 ) had an EC 50 of roughly 200 nM. Transient components measured during cumulative dose responses (Fig. 7, A and B) were much smaller than for a single large increase in concentration ( Figs. 2A and 4A ), which may result from desensitization as observed for prostanoid stimulation of secretory I sc in rabbit ileum (37) . Desensitization could lead to an overestimation of the EC 50 for activation of transient I sc .
The prostanoid antagonist AH-6809, which has species-dependent specificity for EP 1 , EP 2 , EP 3 , DP, and TP prostanoid receptors (1, 10, 38) , distinctly reduced the transient component of the secretory response at a concentration of 100 but not 10 M (Fig. 7C) . The PGE 2 response in the presence of 100 M AH-6809 (Fig. 7C ) Values are means Ϯ SE; n ϭ no. of mucosal samples. bumet, Bumetanide. Cumulative dose responses were fit with binding curves (see Fig. 5 ). Only Isc responses to PGE2, PGD2, and BW-245C required 2 additive binding curves, as well as Gt response to PGE2 (see Tables 1  and 2 ); EC50 for apparent K secretory components also are shown in parentheses. Equivalent EMF of response was calculated as IB /GB; EMF for PGD2 and BW-245C was ill-defined because Gt had a single component and Isc had 2 components. Table 3 . Control and PGE2-stimulated (10 M) conditions are also shown. For tissues with PGD2 or BW-245C, increases stimulated by PGE2 (10 M) were significantly different from zero (P Ͻ 0.05), as indicated by asterisks. Error estimates for Gt (B) were calculated after subtracting control value for each tissue.
was similar in form to the stimulation by agonists for DP and EP prostanoid receptors in the absence of this inhibitor (Fig. 7, A and B) . Bumetanide-insensitive I sc (Fig. 7D) had a transient component that was finished within ϳ2 min, as reported previously (43), indicating that the broad shoulder of the transient component ( Figs. 2A and 4A ) was entirely bumetanide sensitive. In addition, AH-6809 (100 M) reduced the steadystate I sc stimulated by PGE 2 in the presence of bumetanide by 0.71 Ϯ 0.10 eq ⅐ cm Ϫ2 ⅐ h Ϫ1 (n ϭ 6), similar to the difference between PGD 2 and PGE 2 stimulation (Figs. 5A, 6A, and 7D) .
Inhibition of transient I sc by AH-6809 only at high concentration suggests an action via a pathway independent of prostanoid receptors. Weak stimulation of the transient component by DP and EP agonists (Fig.  7, A and B) indicates that neither DP nor EP receptors were primarily involved in this transient I sc response. Prior stimulation with low concentration PGE 2 did not augment substantially the transient component produced by BW-245C (Fig. 4A) , indicating further that combined action at DP and EP receptors was not required to produce this transient response. In addition, sulprostone (1 M), an EP 3 and EP 1 agonist (1, 10, 38), did not augment the transient response with BW-245C (10 M) when added before stimulation, and SC-51322 (1 M), an EP 1 antagonist (1), did not reduce the transient response to PGE 2 (1 M) (data not shown). Absence of a transient response during butaprost stimulation of Cl secretion, as well as during 11dPGE 1 and 19hPGE 2 stimulation, further supports a lack of involvement by EP 2 receptors (Fig. 7B) . Similarly, TP prostanoid receptors were likely not involved in producing the transient I sc response, because the TP agonist I-BOP (300 nM) did not augment the BW-245C (10 M) response and the TP antagonist SQ-29548 (1 M) (1, 10, 38) did not reduce the PGE 2 (1 M) response (data not shown). Together these results support the lack of involvement in this transient I sc response by EP 1 , EP 2 , EP 3 , DP, and TP prostanoid receptors. Thus the pharmacological profile of activation and inhibition suggests that PGE 2 did not stimulate transient Cl Fig. 7 . Transient Isc response to PGE2. Mucosae from the same colon were stimulated with prostanoids. Initial condition followed 3 washes and included indomethacin (2 M), NS-398 (2 M), and amiloride (100 M). A: PGE2, PGD2, and BW-245C were added to serosal solution in cumulative dose responses (Fig. 5) . Change in Isc (⌬current) during step increase from 100 nM to 1 M is shown at time 0. B: PGE2, 11dPGE1, and 19hPGE2 were added to serosal solution in cumulative dose responses (Fig. 3) . ⌬Current during step increase from 100 nM to 1 M is shown at time 0. Butaprost was added in a cumulative dose response to a tissue from another colon (Fig. 3) . ⌬Current during step increase from 300 nM to 1 M is shown at time 0. C: PGE2 was added in the absence or presence of AH-6809 (10 M, 100 M) in serosal solution. PGE2 was added to serosal solution in a cumulative dose response. ⌬Current during step increase from 300 nM to 1 M is shown at time 0; AH-6809 had been present ϳ140 min at time of these PGE2 additions. D: Isc during addition of PGE2 and BW-245C to serosal solution 3 M is shown in the presence of serosal solution bumetanide (100 M). AH-6809 (100 M) was added to serosal solution of one tissue. Bumetanide and AH-6809 had been present ϳ30 min at time of prostanoid addition.
secretion by activating known prostanoid receptors but rather acted through a presently unidentified receptor.
DISCUSSION
Numerous neurotransmitters and locally produced mediators can stimulate colonic ion secretion (4, 8, 20) . Many of these agents work through signaling pathways that converge on production of prostaglandins, which provide the final stimulus to epithelial cells (8, 44, 50, 53) . PGE 2 is an effective stimulator of secretion, and this action has been studied extensively. The chief intracellular second messenger appears to be cAMP (20, 37, 51) , so a reasonable assumption based on prostanoid receptor characteristics (10, 38) would be that PGE 2 acts through EP 2 or EP 4 receptors. In guinea pig distal colon, the PGE 2 dose response for stimulating ion secretion ranges over six orders of magnitude (43) . Identification of the receptors involved in activating this wide-ranging secretory response can be approached more explicitly now because agonist responses of the eight identified prostanoid receptors have been characterized.
Prostanoid receptors. Prostanoid receptors have been classified into eight distinct pharmacological types (10) corresponding with the major prostanoid compounds, PGD 2 , PGE 2 , PGF 2␣ , PGI 2 , and TxA 2 . These receptors are the products of eight identified genes and are expressed in many of the tissues exhibiting specific prostanoid responses (38) . Binding sites for PGE 2 have been detected in rabbit distal colonic crypt epithelial cells with EC 50 values of 0.3 and 11 nM (29) . All four EP receptors were detected in colonic epithelium with in situ hybridization of mRNA for these receptors, although differences between rat (39) and mouse (36) may be caused by variations in relative abundance of mRNA among these receptors. In situ hybridization for mRNA of the DP receptor indicates localization to surface columnar cells of rat colonic epithelium (54) . Interestingly, none of the knockout mice deficient of prostanoid receptors had dramatic intestinal dysfunction (46) .
Establishing a link between a receptor subtype and a cellular function can be accomplished by altering the response with specific activators or inhibitors of the receptors. The presence of the receptor alone would not indicate a signaling connection to a particular response. Efficacy of prostanoid derivatives at prostanoid receptor subtypes has been evaluated recently (1, 5, 31) . Binding of PGE 2 indicated an EC 50 for EP 2 receptors of 5 nM in human (1), 12 nM in mouse (31) , and 7 nM in rat (5). For EP 4 receptors, PGE 2 EC 50 values were 0.8 nM in human (1), 1.9 nM in mouse (31), and 1.1 nM in rat (5). For distinguishing EP subtypes, butaprost is specific for EP 2 and has highest potency when deesterified to the free acid form (1, 5) . Other compounds (1, 5, 31) generally interact with more than one of the EP receptor subtypes and provide less specific determination of subtype involvement. PGE 2 interacts less strongly with DP and FP receptors and only very weakly with IP and TP receptors; EC 50 was 100 nM for human and mouse FP receptor (1, 31) , 300 nM for human DP receptor (1), and Ͼ10 M for human and mouse IP and TP receptors (1, 31) . These receptor affinities for PGE 2 suggest that most physiological actions would be with EP receptors but that at 10-to 300-fold higher concentrations activation of FP and DP receptors might occur.
Colonic secretory response. Secretory activation of distal colonic epithelium by PGE 2 consisted of three major components (Fig. 2 ) that appear to be initiated by three distinct receptor-linked pathways. Electrogenic K secretion was stimulated via EP 2 prostanoid receptors; sustained electrogenic KCl secretion was stimulated via DP prostanoid receptors; and transient electrogenic Cl secretion was stimulated via an unidentified receptor type.
Electrogenic K secretion requires apical membrane K channels together with basolateral membrane Na/K pumps, Na-K-2Cl cotransporters, and, presumably, Cl channels (20, 43) . This K secretory response has the high affinity (EC 50 1-3 nM) for PGE 2 expected of EP receptors (Tables 1 and 3 ). Designation of the response as EP 2 relies primarily on the stimulation by butaprost. Relatively high butaprost affinity suggests that esterases in the mucosa converted the terminal methyl ester to a free acid form, which has higher affinity for EP 2 receptors (1, 5). The inability of sulprostone to stimulate secretion (Fig. 3 ) strongly supports the absence of involvement of EP 3 and EP 1 receptors. Involvement of EP 4 receptors cannot be excluded entirely because of the lack of specific agonists or antagonists. However, because butaprost completely reproduced the K secretory response (Table 1) , EP 2 receptor activation was sufficient for secretory stimulation.
Electrogenic KCl secretion requires apical membrane K and Cl channels together with basolateral membrane Na/K pumps, Na-K-2Cl cotransporters, and K channels (20, 43) . Activation of sustained electrogenic KCl secretion via DP receptors was indicated by the ability of PGD 2 and BW-245C to stimulate this secretion (Figs. 4 and 5 ) with an EC 50 lower than that for PGE 2 (Table 3) . These DP receptor agonists stimulated bumetanide-insensitive I sc (Fig. 6) , suggesting that basolateral Cl uptake also could occur via another transport mechanism to produce Cl secretion.
Transient electrogenic Cl secretion apparently requires apical membrane Cl channels together with basolateral membrane Na/K pumps, Na-K-2Cl cotransporters, and K channels. Stimulation occurred at high PGE 2 concentrations but not via activation of any of the defined prostanoid receptors (Fig. 7, A and B) . The high selectivity for PGE 2 over other prostanoids, however, does suggest action through a specific receptor. A requirement for Na-K-2Cl cotransporters is supported by sensitivity to bumetanide (Figs. 2A, 4A, and 7D ). However, a limited capacity to produce basolateral Cl entry by means other than Na-K-2Cl cotransport is supported by the sustained and bumetanide-insensitive I sc produced by PGE 2 in excess of that produced by BW-245C (Fig. 7D) . Thus this so-called transient response to PGE 2 is best characterized as a nonprostan-oid receptor stimulation of Cl secretion with a large bumetanide-sensitive transient component and a much smaller bumetanide-insensitive sustained component.
All three of these secretory responses appear to involve increases of intracellular cAMP. Both EP 2 and DP prostanoid receptors are linked to stimulation of adenylate cyclase (10, 38) and forskolin, which activates adenylate cyclase, stimulates a large, partially transient Cl secretory response in guinea pig distal colon (43) . Clearly, cAMP alone could not produce these distinct secretory modes unless each occurs in a separate epithelial cell type. Although subpopulations of cells in the colonic epithelia with different receptors are possible, an equally plausible explanation is that each of these receptors produces multiple intracellular second messengers that permit variation in the secretory response. Prostanoid receptor subtypes have been shown to generate more than a single second messenger (38) . In addition, multiple second messengers may be required simply to coordinate the activity of the channels and cotransporters necessary to produce any transepithelial ion flow.
Previous measurements of colonic secretory sensitivity to PGE 2 (or PGE 1 ) generally were taken from peak I sc response and had EC 50 values of 50-3,000 nM. Stimulation of Cl secretory I sc had EC 50 values of 50 nM in canine proximal colon (14, 30, 41) , 60 nM in equine proximal colon (9), ϳ3,000 nM in guinea pig distal colon (50) , ϳ150 nM in porcine distal colon (48) , 200 nM in rabbit distal colon (35) , and ϳ100 nM in rat colon (40) . Stimulation of K secretion in rabbit distal colon had an EC 50 of 100 nM (35) . The basolateral membrane electrical potential difference of rabbit distal colonic crypts depolarized during PGE 2 addition with an EC 50 of ϳ100 nM (34) . The EC 50 obtained did not appear to depend on whether a mucosal or mucosal/ submucosal tissue preparation was used. For the human colonic cell line T84, stimulation of Cl secretory I sc had an EC 50 of 10-30 nM (51, 52) whereas cAMP production had an EC 50 of 100 nM (51) . In light of the high affinity (0.8-12 nM) of EP 2 and EP 4 receptors for PGE 2 (1, 5, 31) , these colonic Cl secretory responses probably result from activation of another class of receptor that binds PGE 2 with lower affinity.
Two major factors may have contributed to a difficulty in recognizing the action of stimulation through EP receptors in colonic epithelia: relatively low rates of K secretion and mucosal production of prostanoids. Rates of K secretion are generally Ͻ1 eq ⅐ cm Ϫ2 ⅐ h Ϫ1 in rabbit, rat, and human distal colon (20, 44) but ϳ3 eq ⅐ cm Ϫ2 ⅐ h Ϫ1 in guinea pig distal colon (43) . In addition, concurrent stimulation of electrogenic K and Cl secretion at high PGE 2 concentrations obscures the extent of activation when only I sc measurements are used to quantify the response. Use of a mucosa preparation largely eliminates secretory influences from enteric nerves (2, 13, 30) so that exogenous stimulation can be more easily interpreted. However, colonic mucosa is capable of producing the five major prostanoids, including PGE 2 (4, 7, 11, 33, 44, 53) , so that K secretion would often be highly stimulated in the initial periods of many experiments. Even in the presence of indomethacin to suppress prostanoid production, guinea pig distal colon (Fig. 1) was apparently stimulated beyond the EC 50 value. Only after in situ stimulators were reduced by rinsing the mucosa were basal secretory rates low enough to allow for ready detection of stimulation by concentrations of PGE 2 in the range of 0.1-10 nM (Figs. 2 and 3) . Similarly, in human jejunum PGE 2 stimulation of Cl secretory I sc occurred with an EC 50 of 1 nM only after suppression of endogenous prostanoids (6) . Together, suppression of endogenous activators and measurements of both I sc and G t allow for a more complete view of colonic secretory responses.
Stimulation of Cl secretion by PGE 2 ( Fig. 3 ; Refs. 9, 14, 30, 34, 35, 40, 41, 48, 50) probably involves lowaffinity activation of DP or FP receptors, based on the PGE 2 affinity of these receptors (1, 5, 31) . Secretory activation by PGD 2 or PGF 2␣ in guinea pig colon, measured from peak I sc , was influenced by nerve and COX activity (16, 17) . Stimulation by PGF 2␣ in canine proximal colon was eliminated by indomethacin (41) . PGD 2 inhibited Cl secretion via enteric nerves in rat distal colon (18) and through a PGD 2 metabolite in canine proximal colon (41) . PGD 2 activation of secretion (Fig.  5) probably was not just an alternate way to stimulate electrogenic KCl secretion; rather, PGE 2 acted through DP receptors because the PGD 2 EC 50 was lower than that for PGE 2 (Table 3) and consistent with EC 50 values for DP receptors (1, 5, 31) . Transient Cl secretion apparently occurred via nonprostanoid receptors with high selectivity for PGE 2 . A similar low-affinity stimulation of Cl secretory I sc occurs in canine proximal colon (42) .
Use of a mucosa preparation and blockade of COX with indomethacin and NS-398 in the present study indicate that the observed secretory activation (Fig. 2) did not occur through release of another prostanoid and support a lack of enteric nerve involvement. Although the three secretory responses of PGE 2 were likely produced via epithelial receptors, stimulation through another cell type remaining in the mucosa cannot be absolutely excluded. However, any response acting through mucosal nerve processes would have to occur without action potential propagation (TTX insensitive) or neurotransmitter release (-CgTx insensitive and atropine insensitive). Because EP and DP receptors are present on epithelial cells (36, 39, 54) and most stimulatory pathways appear to converge on prostanoid release (8) , an epithelial location for these secretion-initiating receptors is consistent with current understanding of mucosal functions.
Bumetanide-insensitive secretory I sc has not been as well characterized as bumetanide-sensitive Cl secretion, but it appears to consist of electrogenic Cl secretion and, depending on the species, a small component of HCO 3 secretion (43, 45) . In guinea pig distal colon, bumetanide-insensitive I sc is dependent on Cl and HCO 3 and is insensitive to hydrochlorothiazide and disulfonic stilbenes (43) , so the mechanism of basolateral Cl uptake remains unclear. The stimulation of bumetanide-insensitive I sc by PGD 2 and BW-245C ( Fig. 6; Table 3 ) indicates that DP receptors activated bumetanide-insensitive as well as bumetanide-sensitive Cl secretion. The nonprostanoid receptor response also includes a small component of bumetanide-insensitive I sc (Figs. 6A and 7D ) in addition to the large bumetanide-sensitive transient I sc component (Fig.  4A) .
Inflammatory conditions. Stimulation of Cl secretion in the colon can be accomplished through activation of several receptor-coupled pathways (8, 20) . PGE 2 -mediated stimulation in epithelial cells apparently involved DP prostanoid receptors. Because both DP and EP 2 receptors can initiate increases of intracellular cAMP (38) , involvement of these two receptor types in secretory activation is consistent with increased intracellular cAMP during PGE 2 addition (51) and the ability of forskolin or theophylline to produce secretion (19, 20) . Other intracellular second messengers probably are involved in each of these receptor-initiated events (38) . Elevation of PGE 2 concentration occurs during various conditions such as bacterial infection, laxative treatment, irritable bowel syndrome, and ulcerative colitis (26, 32) .
Measured PGE 2 ranges over several orders of magnitude depending on the state of the tissue. In isolated mucosa of rabbit distal colon (7), basal levels were in the range of 0.5-2 nM and increased to 20-40 nM during stimulation with arachidonic acid or the calcium ionophore A-32187. Rat colonic epithelial cells generated PGD 2, PGE 2, PGF 2␣ , 6-keto-PGF 1␣ (PGI 2 metabolite), and TxB 2 (TxA 2 metabolite) in roughly similar proportions, although substrate availability may alter the relative production of these prostanoids (11, 33) . Luminal dialysates (32) were ϳ1 nM in colon of healthy humans and were modestly elevated for individuals with Crohn's colitis (5 nM) or Clostridium difficile colitis (3 nM), whereas levels in ulcerative colitis patients were distinctly elevated (44 nM). Prostanoid concentrations near the epithelial cells probably were higher, so levels in healthy individuals might stimulate electrogenic K secretion through EP 2 receptors. Pathophysiological conditions would produce higher PGE 2 levels that presumably could lead to sustained electrogenic KCl secretion via DP receptors and transient Cl secretion via an unidentified eicosanoid receptor.
Isolation of colonic mucosa for in vitro measurement of I sc and G t (Fig. 1) can be viewed as an inflammatory response, because the tissue tearing that separates mucosa from submucosa undoubtedly stimulates production of numerous compounds including eicosanoids such as PGE 2 . In this context, the initial time course of I sc and G t can be seen as a waning of the stimulation produced acutely by inflammatory mediators. With dose responses to PGE 2 (Fig. 3) , changes in I sc and G t (Fig. 1) can be interpreted as effective PGE 2 concentration at secretory epithelial cells in vitro. Initial effective PGE 2 concentration would be ϳ1 M (Fig. 1) , falling rapidly over the first 10 min to ϳ10 nM and stabilizing after ϳ30 min at ϳ4 nM. Estimating mucosal volume as ϳ30 l (0.64-cm 2 area and ϳ500-m thickness), the ϳ300-fold dilution into the serosal bathing solution of released inflammatory mediators was comparable to the ϳ250-fold drop in effective PGE 2 concentration; PGE 2 release occurs predominantly at the serosal side (6) . The first wash dropped effective PGE 2 concentration further to ϳ1 nM, which was followed by a drop to ϳ0.4 nM after the second wash and to ϳ0.3 nM after the third wash. Although these values overestimate PGE 2 concentration by assuming that the stimulation resulted only from endogenous PGE 2 , the final estimated level is just below the range for in vitro PGE 2 measurements (ϳ1-2 nM) from similarly isolated human and rabbit distal colonic mucosa (7, 44) . Although many control pathways ultimately can produce fluid secretion across colonic epithelia (8) , results from this study indicate that of the prostanoid receptors only EP 2 and DP subtypes are likely to be coupled directly for activation of sustained electrogenic K and Cl secretion in secretory epithelial cells. The consequences of these multiple epithelial receptors are that fluid secretory rate and composition can be adjusted more precisely than if a single pathway is used to initiate secretion. Activation of EP 2 receptors would produce a primary secretion of K that creates a lumen positive electrical potential difference driving passive Cl secretion. The fluid produced would have relatively high K concentrations that may contribute to the barrier function of the epithelium. Activation of DP receptors would produce active Cl secretion together with some proportion of K secretion, depending on the species. The amount of K secretion relative to Cl secretion in distal colon varies from roughly equal in guinea pig (43) to ϳ25% of Cl secretion in rabbit (20) and ϳ10% in human (44) . Mucosal mast cells can release PGD 2 (15), so this activation of electrogenic KCl secretion could begin either from an epithelial (11, 33) or an extraepithelial (11, 15, 33) signal. In addition, high concentrations of PGE 2 (2-5 M) stimulated mucus as well as fluid secretion in human colonic crypts (22) ; although the nature of the receptor involved was not determined, fluid secretion was augmented by addition of macromolecules that presumably serve barrier functions of the epithelium. Thus low levels of PGE 2 would produce a fluid of higher K concentration, whereas pathophysiological levels of PGE 2 , generated acutely in response to infection or other inflammatory condition, would produce larger fluid secretion with relatively lower K concentrations.
